Status:
UNKNOWN
Impact of Fluid Status on Liver Elastography and T1-mapping Results in Patients Undergoing CMR.
Lead Sponsor:
Medical University of Vienna
Conditions:
NAFLD/MAFLD
Liver Fibrosis
Eligibility:
All Genders
Brief Summary
Correlation between CMR T1-times, liver T1-times, fibroscan and fluid status to identify the correlation and pathogenesis of liver disease in patients with heart disease.
Eligibility Criteria
Inclusion
- Referred for Cardiovascular Magnetic Resonance Imaging
Exclusion
- Non-compatible Devices
Key Trial Info
Start Date :
February 1 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
January 1 2023
Estimated Enrollment :
150 Patients enrolled
Trial Details
Trial ID
NCT05239260
Start Date
February 1 2022
End Date
January 1 2023
Last Update
February 14 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Medical University Vienna
Vienna, Austria, 1090